AI-driven digital pathology

Agendia is a molecular diagnostics company focused solely on breast cancer, offering genomic testing to personalize early-stage breast cancer treatment. Its MammaPrint and BluePrint tests reveal recurrence risk and tumor biology, with results typically provided within 6 business days. Founded in 2003, the company reports 180+ publications and abstracts, 25,000+ patients enrolled in the FLEX Study, and use of its tests in 45+ countries.

Read more

clinical research and trialsgenomic testingmolecular diagnostics